Global Insights Local Impact
Offer Exclusively For You Save up to Rs. 700/- ON ET PRIME MEMBERSHIP Avail Offer Offer Exclusively For You Get 1 Year Free With 1 and 2-Year ET prime membership Avail Offer Offer Exclusively For You Get 1 Year Free With 1 and 2-Year ET prime membership Avail Offer Offer Exclusively For You Get Flat
Read More
Illustration by Sadhana Saxena via AI. Synopsis Advent, which merged Suven Pharma with Cohance Lifesciences in February, looks to take advantage of the China+1 wave and other geopolitical tailwinds. While the skills of its scientists give India an edge in pharma outsourcing, the scale of local contract manufacturers pales in front of global rivals from
Read More
Synopsis With an alarming rise in cancer diagnosis rate in India, especially among the younger cohort, timely screening and therapeutic intervention are the need of the hour. One small state has devised a unique health model for cancer management and success. Here’s how it can help ensure an improved disease-free survival. Cancer, as a lifestyle
Read More
An overlooked mental health challenge faced by new mothers. A powerful new drug could be critical in fighting back. It should have been an obvious match. Yet things may not turn out that way because of pharma industry’s pricing vagaries as well as the lack of conversation around the condition itself.
Read More
Getty Images Synopsis The new government notice tries to prevent the pharmaceutical companies from inducing doctors to prescribe their medicines through vacations, gifts, and free educational material. It is unlikely to succeed. No free gifts. No free Thailand (or Maldives) trips. No “free lunches” at expensive restaurants. In short, that is the clear message from
Read More
Ranjit Shahani, former chief of Novartis Synopsis Ranjit Shahani will be remembered for his astute leadership and trademark calmness amid chaos. As chief of Novartis in India for nearly two decades, his tenure coincided with unprecedented challenges. Shahani had the tedious task of defending his company from a vexing patent battle while convincing the leadership
Read More
Officials from enforcement agencies with the accused charged with making and supplying spurious drugs; image credit: Telangana Drug Control Administration Synopsis In a rare breakthrough, the Telangana drug administration has unearthed a well-oiled network of spurious drug peddlers with operations spanning from the northern state of India to the narrow alleys of Hyderabad. According to
Read More
Chris Boerner, Global CEO, Bristol Myers Squibb; image credit: BMS Synopsis “We are building to be one of the fastest-growing companies by the end of the decade,” says Chris Boerner, CEO, Bristol Myers Squibb. In an exclusive interaction with ET Prime, Boerner discusses the company’s focus on AI, why it is an exciting time to
Read More
As long-haul infections continue to surge, and climate change pushes ticks into new habitats, finding out the causes of these conditions and coming up with cures will become ever more essential.
Read More
Getty Images Synopsis Orchid Pharma had outlicensed its experimental antibiotic drug to Allecra Therapeutics of Germany. After years of research that drug has won crucial approvals from the US FDA and European drug regulatory agency. This marks an important milestone. The drug, invented by Indian scientists in 2008, takes a big leap in the global
Read More